FDA Inspection 609825 — Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on Aug 19, 2009 in Rancho Cucamonga, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 19, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rancho Cucamonga, CA (United States)

Citations

IDCFRDescription
200521 CFR 211.184(e)Records of disposition of rejected material
439121 CFR 211.180(e)(2)Items to cover on annual reviews

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.